Shares of Nektar Therapeutics (NASDAQ: NKTR) were trading 34.5% lower as of 11:22 a.m. EDT on Friday. The plunge resulted from the biotech's ...
View full coverage on Google Newsfrom Top stories - Google News https://ift.tt/2KpYw0j
Subscribe to:
Post Comments (Atom)
-
By BENJAMIN MUELLER from NYT New York https://ift.tt/2lLfnOi
-
By LAURA LIPPMAN from NYT Opinion https://ift.tt/2KCQH8N
No comments:
Post a Comment